Patents Assigned to Complement Therapeutics Limited
  • AGENTS AND METHODS FOR TREATING COMPLEMENT DISEASES
    Publication number: 20260217791
    Abstract: Polypeptide and nucleic acid agents for treating diseases and conditions associated with complement are disclosed. Also disclosed are expression vectors, compositions and cells comprising the agents, and methods using the agents, e.g. for treatment.
    Type: Application
    Filed: January 5, 2024
    Publication date: July 30, 2026
    Applicant: Complement Therapeutics Limited
    Inventors: Simon J. Clark, Mustafa Munye, Sonika Rathi
  • C3b binding polypeptide
    Patent number: 12544423
    Abstract: Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed arc uses and methods using the polypeptides for treating and preventing diseases and conditions.
    Type: Grant
    Filed: October 20, 2022
    Date of Patent: February 10, 2026
    Assignee: Complement Therapeutics Limited
    Inventors: Paul Bishop, Simon Clark, Richard Unwin
  • C3B binding polypeptide
    Patent number: 12383600
    Abstract: Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed are uses and methods using the polypeptides for treating and preventing diseases and conditions.
    Type: Grant
    Filed: November 4, 2022
    Date of Patent: August 12, 2025
    Assignee: Complement Therapeutics Limited
    Inventors: Paul Bishop, Simon Clark, Richard Unwin
  • C3B binding polypeptide
    Patent number: 11524050
    Abstract: Polypeptides comprising a C3b binding region are disclosed, as well as nucleic acids and vectors encoding such polypeptides, and cells and compositions comprising such polypeptides. Also disclosed are uses and methods using the polypeptides for treating and preventing diseases and conditions.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: December 13, 2022
    Assignee: Complement Therapeutics Limited
    Inventors: Paul Bishop, Simon Clark, Richard Unwin